1. Hemostimulating Effects of c-Jun N-Terminal Kinase (JNK) Inhibitor during Cytostatic Myelosuppression and Mechanisms of Their Development.
- Author
-
Zyuz'kov GN, Zhdanov VV, Miroshnichenko LA, Simanina EV, Polyakova TY, Stavrova LA, Agafonov VI, Minakova MY, Danilets MG, and Ligacheva AA
- Subjects
- Animals, Erythroid Cells drug effects, Erythroid Cells metabolism, Fluorouracil pharmacology, Granulocytes drug effects, Granulocytes metabolism, JNK Mitogen-Activated Protein Kinases antagonists & inhibitors, Mice, Mice, Inbred C57BL, Neutrophils drug effects, Neutrophils metabolism, Reticulocytes drug effects, Reticulocytes metabolism, Signal Transduction drug effects, Cytostatic Agents pharmacology, Hematopoietic Stem Cells drug effects, JNK Mitogen-Activated Protein Kinases metabolism
- Abstract
The hemostimulating effects of c-Jun N-terminal kinase (JNK) inhibitor were examined on the mouse model of myelosuppression provoked by 5-fluorouracil. Blockade of JNK during postcytostatic period accelerated recovery of granulomonocytopoiesis and erythropoiesis. It also increased the content of neutrophilic granulocytes and erythroid cells in the hematopoietic tissue and elevated the counts of neutrophils and reticulocytes in the peripheral blood. The development of these phenomena resulted from elevated content and up-regulated functional activity of bone marrow hematopoietic progenitors associated with the direct action of JNK inhibitor on these progenitors and enhanced secretion of hemopoietins by stromal elements of the hematopoiesis-inducing microenvironment.
- Published
- 2020
- Full Text
- View/download PDF